» Articles » PMID: 18682897

Chemopreventive Effect of Lycopene Alone or with Melatonin Against the Genesis of Oxidative Stress and Mammary Tumors Induced by 7,12 Dimethyl(a)benzanthracene in Sprague Dawely Female Rats

Overview
Publisher Springer
Specialty Biochemistry
Date 2008 Aug 7
PMID 18682897
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the principle cause of death among women worldwide. In this study, we investigated the anti-tumor potential of lycopene (Lyco) alone or combined with melatonin (Lyco + Mel) for 120 days against a single oral dose of (50 mg/kg B.W.) 7,12-dimethylbenz(a)anthracene (DMBA)-induced oxidative stress and mammary carcinogenesis in female rats. The treatment protocol started from the day immediately after DMBA administration. Results obtained indicated that there was an elevation in the levels of malondialdhyde and nitric oxide in serum and breast tissues of DMBA injected rats. The combined treatment (Lyco + Mel) group showed a potential reduction of these parameters more than lyco individually. The activities of SOD, CAT, and GPx were found to be significantly high than lyco alone treated rats. In DMBA group a negative significant correlation between weight and serum nitric oxide (r = -0.59), and a positive significant correlation between NO and MDA (r = 0.81) was observed. Histopathological examination revealed the formation of tumor and angiogenesis in DMBA-induced rats and these abnormal changes were ameliorated by combined treatment with Lyco + Mel. In conclusion, these results suggested that supplementation of diet with lycopene with melatonin provided antioxidant defense with strong chemo preventive activity against DMBA-induced mammary tumors.

Citing Articles

Melatonin: a modulator in metabolic rewiring in T-cell malignancies.

Rai S, Roy G, Hajam Y Front Oncol. 2024; 13:1248339.

PMID: 38260850 PMC: 10800968. DOI: 10.3389/fonc.2023.1248339.


Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review.

Ramos E, Egea J, Lopez-Munoz F, Gil-Martin E, Romero A Pharmaceutics. 2023; 15(6).

PMID: 37376065 PMC: 10303424. DOI: 10.3390/pharmaceutics15061616.


Allyl isothiocyanate inhibits invasion and angiogenesis in breast cancer via EGFR-mediated JAK-1/STAT-3 signaling pathway.

Rajakumar T, Pugalendhi P Amino Acids. 2023; 55(8):981-992.

PMID: 37310534 DOI: 10.1007/s00726-023-03285-2.


Antitumor and Antibacterial Efficacy of Gallium Nanoparticles Coated by Ellagic Acid.

El-Sonbaty S, Moawed F, Kandil E, M Tamamm A Dose Response. 2022; 20(1):15593258211068998.

PMID: 35173563 PMC: 8841935. DOI: 10.1177/15593258211068998.


An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.

Mehrzadi S, Pourhanifeh M, Mirzaei A, Moradian F, Hosseinzadeh A Cancer Cell Int. 2021; 21(1):188.

PMID: 33789681 PMC: 8011077. DOI: 10.1186/s12935-021-01892-1.


References
1.
Weydert C, Waugh T, Ritchie J, Iyer K, Smith J, Li L . Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med. 2006; 41(2):226-37. DOI: 10.1016/j.freeradbiomed.2006.03.015. View

2.
Astorg P, Gradelet S, Berges R, Suschetet M . Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr Cancer. 1997; 29(1):60-8. DOI: 10.1080/01635589709514603. View

3.
Mehta R . Experimental basis for the prevention of breast cancer. Eur J Cancer. 2000; 36(10):1275-82. DOI: 10.1016/s0959-8049(00)00100-3. View

4.
Gerster H . The potential role of lycopene for human health. J Am Coll Nutr. 1997; 16(2):109-26. DOI: 10.1080/07315724.1997.10718661. View

5.
Bray F, McCarron P, Parkin D . The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004; 6(6):229-39. PMC: 1064079. DOI: 10.1186/bcr932. View